Ratio of 8-hydroxyguanine in intact DNA to free 8-hydroxyguanine is increased in Alzheimer disease ventricular cerebrospinal fluid

被引:114
作者
Lovell, MA
Markesbery, WR
机构
[1] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA
[2] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
[3] Univ Kentucky, Dept Pathol, Lexington, KY 40536 USA
[4] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA
关键词
D O I
10.1001/archneur.58.3.392
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Markers of oxidative stress are increased in cerebrospinal fluid (CSF) of patients with Alzheimer disease (AD), although none of those reported are appropriate diagnostic markers because of the overlap between patients with AD and control subjects. Objective: To determine the ratio of 8-hydroxyguanine (8-OHG) levels in intact DNA to free 8-OHG in the ventricular CSF of patients with AD and age-matched control subjects. The most prominent marker of DNA oxidation-is 8-OHG. Methods: Free 8-hydroxy 2'-deoxyguanosine (8-OHdG) was isolated from ventricular CSF taken at autopsy from 18 subjects with AD and 7 control subjects using solid-phase extraction columns. Levels were measured as the hydrolysis product, 8-OHG, using gas chromatography/mass spectrometry with selective ion monitoring. Intact DNA was isolated from the same CSF and the levels of 8-OHG were determined in the intact structures. Stable-labeled 8-OHG was used for quantification. Results: A statistically significant (P<.05) 108-fold increase in the ratio of 8-OHG in intact DNA to free 8-OHG was observed in patients with AD. Analysis of the data distribution indicated that the lowest AD ratio was 3.5 times higher than the highest control ratio; there was no overlap of the 2 populations. Conclusion: although the data for each individual measurement demonstrates overlap between patients with AD and control subjects, the ratio of 8-OHG intact in DNA to free 8-OHG demonstrates a delineation between patients with AD and control 8-OHG subjects and may be useful as a marker of disease progression or the efficacy of therapeutic antioxidant intervention.
引用
收藏
页码:392 / 396
页数:5
相关论文
共 33 条
  • [1] OXIDATIVE DAMAGE TO DNA - RELATION TO SPECIES METABOLIC-RATE AND LIFE-SPAN
    ADELMAN, R
    SAUL, RL
    AMES, BN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) : 2706 - 2708
  • [2] [Anonymous], 1997, Neurobiol Aging, V18, pS1
  • [3] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [4] BRAAK H, 1994, NEURODEGENERATIVE DI, V585, P613
  • [5] Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease
    Calingasan, NY
    Uchida, K
    Gibson, GE
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) : 751 - 756
  • [6] AN ENDONUCLEASE ACTIVITY IN HUMAN POLYMORPHONUCLEAR NEUTROPHILS THAT REMOVES 8-HYDROXYGUANINE RESIDUES FROM DNA
    CHUNG, MH
    KIM, HS
    OHTSUKA, E
    KASAI, H
    YAMAMOTO, F
    NISHIMURA, S
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 178 (03) : 1472 - 1478
  • [8] OXIDATIVE DAMAGE TO DNA DURING AGING - 8-HYDROXY-2'-DEOXYGUANOSINE IN RAT ORGAN DNA AND URINE
    FRAGA, CG
    SHIGENAGA, MK
    PARK, JW
    DEGAN, P
    AMES, BN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (12) : 4533 - 4537
  • [9] Increased nuclear DNA oxidation in the brain in Alzheimer's disease
    Gabbita, SP
    Lovell, MA
    Markesbery, WR
    [J]. JOURNAL OF NEUROCHEMISTRY, 1998, 71 (05) : 2034 - 2040
  • [10] High cerebrospinal fluid tau and low amyloid β42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype
    Galasko, D
    Chang, L
    Motter, R
    Clark, CM
    Kaye, J
    Knopman, D
    Thomas, R
    Kholodenko, D
    Schenk, D
    Lieberburg, I
    Miller, B
    Green, R
    Basherad, R
    Kertiles, L
    Boss, MA
    Seubert, P
    [J]. ARCHIVES OF NEUROLOGY, 1998, 55 (07) : 937 - 945